Procaps Group (Procaps Group) EV-to-Revenue : 1.35 (As of Jun. 19, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Procaps Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Procaps Group's enterprise value is $557.4 Mil. Procaps Group's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $414.1 Mil. Therefore, Procaps Group's EV-to-Revenue for today is 1.35.

The historical rank and industry rank for Procaps Group's EV-to-Revenue or its related term are showing as below:

PROC' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.18 Med: 1.76 Max: 3.12
Current: 1.35

During the past 4 years, the highest EV-to-Revenue of Procaps Group was 3.12. The lowest was 1.18. And the median was 1.76.

PROC's EV-to-Revenue is ranked better than
69.42% of 1017 companies
in the Drug Manufacturers industry
Industry Median: 2.24 vs PROC: 1.35

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-19), Procaps Group's stock price is $2.60. Procaps Group's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $4.07. Therefore, Procaps Group's PS Ratio for today is 0.64.

Procaps Group EV-to-Revenue Historical Data

The historical data trend for Procaps Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procaps Group EV-to-Revenue Chart

Procaps Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

EV-to-Revenue

3.12

2.04

Procaps Group Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EV-to-Revenue	Get a 7-Day Free Trial											2.33	2.04	1.89	1.85	1.62

Competitive Comparison of Procaps Group's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Procaps Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Procaps Group's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procaps Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Procaps Group's EV-to-Revenue falls into.

Procaps Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Procaps Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	557.432	/	414.096
	=	1.35

Procaps Group's current Enterprise Value is $557.4 Mil.
Procaps Group's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $414.1 Mil.

Procaps Group (NAS:PROC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Procaps Group's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	2.60	/	4.071
	=	0.64

Procaps Group's share price for today is $2.60.
Procaps Group's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.07.

Procaps Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Procaps Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Procaps Group (Procaps Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procaps Group SA (NAS:PROC) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

9X1:Germany

Address

9 Rue de Bitbourg, Luxembourg, LUX, L-1273

Website

https://www.procapsgroup.com

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Executives

Alexandre Weinstein Manieu	director, 10 percent owner	CHASHAM PLACE, FLAT 1, LONDON X0 SW1X 8HG
Ruben Minski	director, 10 percent owner, officer: Chief Executive Officer	9 RUE DE BITBOURG, C/O PROCAPS GROUP, S.A., LUXEMBOURG N4 L-1273
Jose Minski	director, 10 percent owner	9 RUE DE BITBOURG, C/O PROCAPS GROUP, S.A., LUXEMBOURG N4 L-1273
Sognatore Trust	10 percent owner	OFICINA 503A-02, EDIFICIO QUANTUM, (500) RUTA 8 KM. 17.500 ZONAMERICA, MONTEVIDEO X3 91600
Simphony Trust	10 percent owner	29 BANCROFT MILLS ROAD, WILMINGTON DE 19806
Deseja Trust	10 percent owner	29 BANCROFT MILLS ROAD, WILMINGTON DE 19806
Hoche Partners Pharma Holding S.a.	10 percent owner	3A VAL SAINTE CROIX, LUXEMBOURG N4 L-1371